- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04100850
Effectiveness of Aquatic Exercises for Improving Mental and Physical Health in Adults. (AEforMH)
May 9, 2023 updated by: Rodrigo Gustavo da Silva Carvalho, Universidade Federal do vale do São Francisco
Effectiveness of Aquatic Exercises for Improving Mental and Physical Health in Adults: Randomized Clinical Trial
Objective: To compare the effectiveness between aquatic exercises (water aerobics versus Watsu) versus control groups, for improving the outcomes of depression, anxiety, stress, sleep quality, functionality, cognition and quality of life in patients with depression.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Introduction: Considered as the "21st century disease", depression is a silent disease that stands out for its high prevalence and high morbidity, leading to serious consequences.
With treatments made in aquatic environment, among them the Water aerobics and Watsu.
Objective: To compare the effectiveness between aquatic exercises versus Watsu and versus control group, for improving the outcomes of depression, anxiety, stress, sleep quality, functionality, cognition and quality of life in patients with depression.
Methods: This study will be a randomized clinical trial, which will last for two months with a follow-up of one month.
All participants will be assessed using specific questionnaires for each outcome and an Improvement Perception Scale (MS).
Seventy eight (78) patients with a medical diagnosis of depression, aged 18 to 60 years, who will be allocated to three groups (26 patients for each group) will be treated.
GROUP 1: Aquatic exercises (aerobic and resistance), collective session, twice a week lasting 50 min; GROUP 2: Watsu (water shiatsu), individual session, twice a week lasting 50 min; Group 3: control, people with depression.
Statistical analysis: Normality distribution will be by Shapiro-Wilk test.
For comparisons of the means between and within the outcome groups will be used through Generalized Estimation Equations, with its own syntax, linear distribution and, when necessary, multiple comparisons will be performed using the Bonferroni test to identify differences.
Will be calculated for comparisons between the final and initial moments and initial follow-up in each group, statistics such as: mean difference (95% CI), standard deviation of the difference, effect size (Cohen's d).
The statistical significance adopted was 5% and the analyzes were performed using the statistical programs SPSS 22.0 and R 3.2.4.
The intention-to-treat analysis will be performed.
Study Type
Interventional
Enrollment (Anticipated)
78
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rodrigo GS Carvalho, PhD
- Phone Number: +5587999832015
- Email: rodrigocarvalhofisio@gmail.com
Study Contact Backup
- Name: Rodrigo GS Carvalho, PhD
- Phone Number: +558721016856
- Email: rodrigo.carvalho@univasf.edu.br
Study Locations
-
-
Pernambuco
-
Petrolina, Pernambuco, Brazil, 56304917
- Recruiting
- Physical Education College
-
Contact:
- Rodrigo GS Carvalho, PhD
- Phone Number: 8721016856
- Email: rodrigo.carvalho@univasf.edu.br
-
Contact:
- Rodrigo GS Carvalho, PhD
- Phone Number: 8721016856
- Email: rodrigocarvalhofisio@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age between 18 and 60 years old;
- Sedentary and who have not had physical therapy and physical activity in the last three months;
- Clinical and cognitive conditions for performing pool activities and moderate aerobic exercise;
- Who have not undergone high complexity surgical procedures in the last six months; no neuro-musculosqueletal diseases;
- No contraindications to exercise; such as: urinary and / or fecal incontinence and dermatological diseases;
- Individuals with a medical diagnosis of depression.
Exclusion Criteria:
- If they have up to three absences during the intervention period;
- If they have any adverse effects, such as: allergy or dermatitis;
- Unable to continue study due to change of address or hospitalization.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Aquatic Exercises
Aquatic Exercises (AE) are water aerobics exercises and resistance exercises, classes will be supervised by a Physical Educator, in collective sessions of up to 30 people per class, twice a week, lasting 50 minutes, for two months.
|
twice a week, lasting 50 minutes, for two months.
Other Names:
|
Active Comparator: Watsu
The Watsu (water shiatsu) will be applied by a physical therapist, in individual sessions, twice a week, lasting 50 minutes, for two months in a warn pool (± 34°C).
Watsu in particular prescribes transition of movements, once they are instituted, the therapist can create and adapt according to the limitations and restrictions that are encountered.
|
twice a week, lasting 50 minutes, for two months.
Other Names:
|
No Intervention: Control
The control group will not receive any of these treatments (aquatic exercises and Watsu).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression
Time Frame: change depression at 8 weeks and follow-up at 12 weeks
|
Beck Depression Inventory (better 0-63 worse points)
|
change depression at 8 weeks and follow-up at 12 weeks
|
Anxiety
Time Frame: change anxiety at 8 weeks and follow-up at 12 weeks
|
Beck Anxiety Inventory (better 0-63 worse points)
|
change anxiety at 8 weeks and follow-up at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stress
Time Frame: change stress at 8 weeks and follow-up at 12 weeks
|
Depression, Anxiety and Stress Scale (DASS-21) (better 0 - worse >34)
|
change stress at 8 weeks and follow-up at 12 weeks
|
Quality of Life Questionnaire
Time Frame: change quality of live at 8 weeks and follow-up at 12 weeks
|
12-Item Short-Form Health Survey (SF-12) (worse 0 - better 100)
|
change quality of live at 8 weeks and follow-up at 12 weeks
|
Sleep Quality
Time Frame: change sleep quality at 8 weeks and follow-up at 12 weeks
|
Pittsburgh Sleep Quality Index (PSQI) (better 0 - worse 21)
|
change sleep quality at 8 weeks and follow-up at 12 weeks
|
Life Style Scale
Time Frame: change life style at 8 weeks and follow-up at 12 weeks
|
Fantastic Life Style Scale (worse 0 - better 100)
|
change life style at 8 weeks and follow-up at 12 weeks
|
Cognitive
Time Frame: change cognitive at 8 weeks and follow-up at 12 weeks
|
Montreal Cognitive Assessment (MOCA) (worse 0 - better 30)
|
change cognitive at 8 weeks and follow-up at 12 weeks
|
Functionally
Time Frame: change functionally at 8 weeks and follow-up at 12 weeks
|
Six-minute Walk Test (6m-WT)
|
change functionally at 8 weeks and follow-up at 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement Perception
Time Frame: pos (8 week)
|
Improvement Perception Scale (0-7)
|
pos (8 week)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Rodrigo GS Carvalho, PhD, Physical Education College / UNIVASF
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2019
Primary Completion (Anticipated)
December 31, 2023
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
September 20, 2019
First Submitted That Met QC Criteria
September 23, 2019
First Posted (Actual)
September 24, 2019
Study Record Updates
Last Update Posted (Actual)
May 10, 2023
Last Update Submitted That Met QC Criteria
May 9, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AE-Mental
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Study Protocol, Randomized Clinical Trial
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Aquatic Exercises
-
Cairo UniversityRecruitingAutism Spectrum DisorderEgypt
-
Universidade Federal do Rio Grande do NorteCompleted
-
Riphah International UniversityRecruitingLow Back Pain | Hydrotherapy | Resistance Training | Core StabilityPakistan
-
Universidade Estadual de LondrinaMinistry of Health, Brazil; Fundação AraucáriaCompleted
-
Dokuz Eylul UniversityCompletedMultiple Sclerosis, Relapsing-RemittingTurkey
-
Parc de Salut MarEuropean Regional Development Fund; Consorcio Centro de Investigación Biomédica... and other collaboratorsCompletedPost-COVID-19 SyndromeSpain
-
Riphah International UniversityCompleted
-
Cairo UniversityCompletedCerebral PalsySaudi Arabia
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulCompleted
-
University of Sao Paulo General HospitalInstituto Dante Pazzanese de CardiologiaUnknownCongestive Heart FailureBrazil